Burnout in the Knowledge Economy: Does Your Company Put Enough Value in Rest?

Productivity and rest represent two sides of a scale that continually need to be balanced. They each lose their luster when the balance is off, […] The post Burnout in the Knowledge Economy: Does Your Company Put Enough Value in Rest? appeared first on e-Learning Feeds. Powered by WPeMatico Continue reading Burnout in the Knowledge Economy: Does Your Company Put Enough Value in Rest?

The UK’s New Statutory Scheme for Pricing of Branded Medicines

With a new consultation from the UK s Department of Health proposing changes to the Statutory Scheme for Pricing of Branded Medicines essentially the back-stop to the voluntary Pharmaceutical Price Regulation Scheme (PPRS) what could this mean for negotiation of a successor to the 2014 PPRS? Powered by WPeMatico Continue reading The UK’s New Statutory Scheme for Pricing of Branded Medicines

Busy Congress Unlikely to Act on Drug Pricing Legislation This Fall

Despite multiple proposals on Capitol Hill that target the high cost of prescription drugs, a long list of high priority issues requiring immediate attention leaves little time to consider drug access proposals that have limited bipartisan support. Even the clamor for action to counter the natio Powered by WPeMatico Continue reading Busy Congress Unlikely to Act on Drug Pricing Legislation This Fall

Avoiding a CIA: Analytics and the Search for Dangerous Data

When it comes to promoting compliance in the pharmaceutical industry, corporate integrity agreements (or CIAs ) may be the most important and most onerous tools in the government s toolbox. The U.S. Department of Health and Human Services Office of the Inspector General ( OIG ) issues CI Powered by WPeMatico Continue reading Avoiding a CIA: Analytics and the Search for Dangerous Data

Leveraging Health IT to Improve Drug Development

Health information technology health IT enables the comprehensive management of medical information and its secure exchange between patients and providers. Health IT has revolutionized healthcare at every stage of delivery. For instance, health IT has allowed patients to gain access to their med Powered by WPeMatico Continue reading Leveraging Health IT to Improve Drug Development

Upgrading Adherence: Patient Insights in the Age of AI

One of the greatest cost drivers in healthcare is still hiding in plain sight. It s called medication nonadherence. So began an article in Forbes last month by Hayden Bosworth, professor of medicine, psychiatry, and nursing at Duke University Medical Center, and Prescriptions for a Healthy Powered by WPeMatico Continue reading Upgrading Adherence: Patient Insights in the Age of AI

Deregulation Helps Pharma Companies Pursue Digital Health Strategies

Let s say your company has developed a drug for adults with ADHD. However, fewer than 20% of adults with ADHD are currently diagnosed by psychiatrists, in part because ADHD presents differently in adults than it does in children (1). Your company wants to change that through a digital strategy t Powered by WPeMatico Continue reading

Deregulation Helps Pharma Companies Pursue Digital Health Strategies